Recent Analysis on vaccine Adjuvants Market Research Report

Albany/New York
Pune/India, April, 2017.

Marketresearchdata.net has added a new report on Global vaccine Adjuvants Market. The report predicts the market size of Global vaccine Adjuvants Market is expected to reach XX billion by 2021.

The report covers the analysis of global as well as regional markets of Global vaccine Adjuvants Market. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.

Adjuvants have been used for decades to improve the immune response to vaccine antigens. They improve the body’s immune response and often allow for smaller amounts of an inactivated virus or bacteria to be used in a vaccine. However, more than one adjuvant may be present in the final vaccine product. Aluminium salts, such as aluminium hydroxide, aluminium phosphate and aluminium potassium sulfate have been used safely in vaccines for more than 70 years.
The demand for this market is expected to increase as adjuvants will be required to enhance and extend immune responses while reducing the amount of antigen necessary in each dose. The limited immunogenicity of new and novel vaccine antigens has increased the importance of adjuvant research in vaccine development. There is a need for the development of safe and non-toxic adjuvants. Vaccines containing novel adjuvant formulations are increasingly reaching advanced development and licensing stages, providing new tools to fill previously unmet clinical needs. However, many adjuvants fail during product development owing to factors such as manufacturability, stability, lack of effectiveness, unacceptable levels of tolerability and safety concerns.
The vaccine adjuvants market can be segmented by the type of adjuvant (mineral based adjuvants, tensioactive adjuvants, adjuvant emulsions, bacteria derived adjuvants, liposome adjuvants, carbohydrate adjuvants, organic adjuvants, cytokines, virus like particles, TLR-based adjuvants and others), by mechanism of action (active immunostimulants, carriers, vehicle adjuvants) and by geography (North America, Europe, APAC and the Rest of the World).
Competitive Intelligence analysis in the form of mergers & acquisition activity, collaborations, agreements, new product launches along with the profiles of major players including InvivoGen, Sigma Aldrich, SEPPIC, OZ Biosciences, Novavax, Adjuvatis, VaxLiant and Adjuvance Technologies have been included in the report.

To access full report visit @ http://marketresearchdata.net/Reports/global-vaccine-adjuvants-market-research-report-to-2021

Table of Content

  1. INTRODUCTION
    1.1 REPORT DESCRIPTION
    1.2 STUDY DELIVERABLES
    1.3 STUDY ASSUMPTIONS
    1.4 MARKET DEFINITION
    2. RESEARCH METHODOLOGY
    2.1 INTRODUCTION
    2.2 ANALYSIS METHODOLOGY
    2.3 STUDY TIMELEINE
    2.4 STUDY PHASES
    2.4.1 SECONDARY RESEARCH
    2.4.2 DISCUSSION GUIDE
    2.4.3 MARKET ENGINEERING AND ECONOMETRIC MODELLING
    2.4.4 EXPERT VALIDATION
    3. MARKET DYNAMICS
    3.1 MARKET DRIVERS
    3.2.1 EXPANDING GOVERNMENT RECOMMENDATIONS FOR IMMUNIZATIONS
    3.2.2 TECHNOLOGICAL INNOVATIONS
    3.2.3 UNMET VACCINE MARKET NEEDS FOR CERTAIN DISEASES
    3.2.4 INCREASING USE OF RECOMBINANT SUBUNIT AND SYNTHETIC VACCINES
    3.2 MARKET RESTRAINTS
    3.2.1 SIDE EFFECTS OF ADJUVANTS
    3.2.2 HIGH TOXICITY ADJUVANTS
    3.2.3 HIGH R&D COST OF DEVELOPING A NEW ADJUVANT
    3.3 MARKET OPPORTUNITY
    3.3.1 GROWTH IN EMERGING ECONOMIES
    3.4 MARKET CHALLENGES
    3.4.1 REGULATORY ISSUES
    3.5 PORTERS FIVE FORCE ANALYSIS
    3.5.1 THREAT OF NEW ENTRANTS:
    3.5.2 THREAT OF SUBSTITUTE PRODUCTS OR SERVICES:
    3.5.3 BARGAINING POWER OF CUSTOMERS (BUYERS)
    3.5.4 BARGAINING POWER OF SUPPLIERS
    3.5.5 INTENSITY OF COMPETITIVE RIVALRY
    4. MARKET SEGMENTATION
    4.1 BY TYPE
    4.1.1 MINERAL SALT BASED ADJUVANTS
    4.1.2 TENSIOACTIVE ADJUVANTS
    4.1.3 ADJUVANT EMULSIONS
    4.1.4 LIPOSOMES ADJUVANTS
    4.1.5 CARBOHYDRATE ADJUVANTS
    4.1.6 BACTERIA DERIVED ADJUVANTS
    4.1.7 ORGANIC ADJUVANT
    4.1.8 CYTOKINES
    4.1.9 VIRUS LIKE PARTICLES (VLP)
    4.1.10 TLR BASED ADJUVANTS
    4.1.10 OTHERS
    4.2 BY MECHANISM OF ACTION
    4.2.1 ACTIVE IMMUNOSTIMULANTS
    4.2.2 CARRIERS
    4.2.3 VEHICLE ADJUVANTS
    4.3 BY GEOGRAPHY
    4.3.1 NORTH AMERICA
    4.3.1.1 USA
    4.3.1.2 CANADA
    4.3.1.3 MEXICO
    4.3.2 EUROPE
    4.3.2.1 UNITED KINGDOM (UK)
    4.3.2.2 GERMANY
    4.3.2.3 FRANCE
    4.3.2.4 ITALY
    4.3.2.5 SPAIN
    4.3.2.6 REST OF EUROPE
    4.3.3 ASIA-PACIFIC
    4.3.3.1 JAPAN
    4.3.3.1 CHINA
    4.3.3.3 INDIA
    4.3.3.4 AUSTRALIA
    4.3.3.5 OTHERS
    4.3.4 REST OF THE WORLD (ROW)
    5. COMPETITIVE LANDSCAPE
    5.1 MERGERS & ACQUISITIONS
    5.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
    5.3 NEW PRODUCT LAUNCHES
    6. COMPANY PROFILES
    6.1 INVIVOGEN INC.
    6.1.1 BUSINESS OVERVIEW:
    6.1.2 PRODUCTS AND SERVICES:
    6.1.3 FINANCIAL OVERVIEW:
    6.2 SIGMA ALDRICH CORPORATION
    6.2.1 BUSINESS OVERVIEW:
    6.2.2 PRODUCTS & SERVICES:
    6.2.3 FINANCIAL OVERVIEW:
    6.3 SEPPIC S.A.
    6.3.1 BUSINESS OVERVIEW:
    6.3.2 PRODUCTS & SERVICES:
    6.3.3 FINANCIAL OVERVIEW:
    6.4 OZ BIOSCIENCES
    6.4.1 BUSINESS OVERVIEW
    6.4.2 PRODUCTS & SERVICES
    6.4.3 FINANCIAL OVERVIEW:
    6.5 NOVAVAX, INC.
    6.5.1 BUSINESS OVERVIEW:
    6.5.2 PRODUCTS & SERVICES:
    6.5.3 FINANCIAL OVERVIEW:
    6.6 ADJUVATIS SAS
    6.6.1 BUSINESS OVERVIEW:
    6.6.2 PRODUCTS & SERVICES:
    6.6.3 FINANCIAL OVERVIEW:
    6.7 VAXLIANT LLC
    6.7.1 BUSINESS OVERVIEW:
    6.7.2 PRODUCTS & SERVICES:
    6.7.3 FINANCIAL OVERVIEW:
    6.8 ADJUVANCE TECHNOLOGIES, INC
    6.8.1 BUSINESS OVERVIEW:
    6.8.2 PRODUCTS & SERVICES:
    6.8.3 FINANCIAL OVERVIEW:
    6.9 BRENNTAG AG
    6.9.1 BUSINESS OVERVIEW:
    6.9.2 PRODUCTS & SERVICES:
    6.9.3 FINANCIAL OVERVIEW:
    6.10 GLAXOSMITHKLINE PLC
    6.10.1 BUSINESS OVERVIEW:
    6.10.2 PRODUCTS & SERVICES:
    6.10.3 FINANCIAL OVERVIEW:
    6.11 APHIOS CORPORATION:
    6.11.1 BUSINESS OVERVIEW:
    6.11.2 PRODUCTS & SERVICES:
    6.11.3 FINANCIAL OVERVIEW:
    6.12 BOEHRINGER INGELHEIM VETMEDICA, INC.
    6.12.1 BUSINESS OVERVIEW:
    6.12.2 PRODUCTS AND SERVICES
    6.12.3 FINANCIAL OVERVIEW:
    6.13 VAXINE PTY LTD
    6.13.1 BUSINESS OVERVIEW
    6.13.2 PRODUCTS & SERVICES
    6.13.3 FINANCIAL OVERVIEW
    6.14 AGENUS INC.
    6.14.1 BUSINESS OVERVIEW
    6.14.2 PRODUCTS & SERVICES
    6.14.3 FINANCIAL OVERVIEW
    7. ANALYST OUTLOOK FOR INVESTMENT OPPORTUNITY
    8. FUTURE OUTLOOK OF THE MARKET

To make an enquiry about report visit:

http://marketresearchdata.net/Reports/MakeEnquiryRequest/113.html
Reasons to buy this report:
1) Deep insights and comprehensive analysis of global and regional markets
2) Complete coverage of key product types and application segments and their sub-segments through geographies and world market
3) Deep dive into the market share and recent developments of the key players in the industry.
4) Analysis and presentation of evolving market trends, patterns, technological advancements
5) Presentation of market dynamics and factors bearing control over the global and regional markets.
6) Competitive landscapes and insights
7) Opportunity mapping in terms of product developments, research and developments and technological advancements.
To know more about us Visit:
http://marketresearchdata.net/Welcome/About.html

Reasons to choose marketresearchdata.net
1) 24X7 sales support and free analyst time for post purchase queries.
2) Exclusive support from the analysts and industry experts possessing experience over 5 years in the industry
3) Long term relationship management and exclusivity benefits for our clients
 

To make sample request for report visit:
http://marketresearchdata.net/Reports/MakeSampleRequest/113.html
Contact Us:
USA/Canada Toll Free: +18006380796
Rest of the World: +919765091631
Email: sales@marketresearchdata.net
website: http://www.marketresearchdata.net

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s